[1]
Dr Gaurav Thukral, Dr Vipulkumar Thummar, Dr Priya Mehta, Dr. Vijay Janagama, and Keyur Khambhati, “Drug Utilization Pattern of World’s First T-DM1 Biosimilar (UJVIRATM) For Her2+ Breast Cancer in First Year of Its Availability – An Indian Context”, ijmsci, vol. 10, no. 02, pp. 6561–6568, Feb. 2023.